MétaCan
Menu
Back to cohort

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

2023· article· en· W4367856691 on OpenAlexafffund
Roni Tamari, Donal P. McLornan, Kwang Woo Ahn, Noel Estrada‐Merly, Juan Carlos Hernández‐Boluda, Sergio Giralt, Jeanne Palmer, Robert Peter Gale, Zachariah DeFilipp, David I. Marks, Marjolein van der Poel, Leo F. Verdonck, Minoo Battiwalla, Miguel Ángel Díaz, Vikas Gupta, Haris Ali, Mark R. Litzow, Hillard M. Lazarus, Usama Gergis, Asad Bashey, Jane L. Liesveld, Shahrukh K. Hashmi, Jeffrey J. Pu, Amer Beitinjaneh, Christopher Bredeson, David A. Rizzieri, Bipin N. Savani, Muhammad Bilal Abid, Siddhartha Ganguly, Vaibhav Agrawal, Ulrike Bacher, Baldeep Wirk, Tania Jain, Corey Cutler, Mahmoud Aljurf, Tamila L. Kindwall‐Keller, Mohamed A. Kharfan‐Dabaja, Gerhard Hildebrandt, Attaphol Pawarode, Melhem Solh, Jean A. Yared, Michael R. Grunwald, Sunita Nathan, Taiga Nishihori, Sachiko Seo, Bart L. Scott, Ryotaro Nakamura, Betül Oran, Tomasz Czerw, Ibrahim Yakoub‐Agha, Wael Saber

Bibliographic record

VenueBlood Advances · 2023
Typearticle
Languageen
FieldMedicine
TopicMyeloproliferative Neoplasms: Diagnosis and Treatment
Canadian institutionsOttawa HospitalPrincess Margaret Cancer CentreUniversity of Toronto
FundersCancer MoonshotMoonshot Research and Development ProgramNational Institute of Allergy and Infectious DiseasesNational Cancer InstituteOffice of Naval ResearchLegend BiotechAdaptive BiotechnologiesHealth Resources and Services AdministrationKite PharmaDaiichi Sankyo EuropeAgios PharmaceuticalsTakeda OncologyAstraZenecaGenentechNational Institutes of HealthMorphoSysInvitaeVertex PharmaceuticalsOno PharmaceuticalMazak FoundationCardinal HealthCareDxBeiGeneSwedish Orphan BiovitrumAstellas PharmaGlaxoSmithKlineKiadis PharmaPharmacyclicsbluebird bioSanofiTG TherapeuticsOmeros CorporationMedical College of WisconsinStemCyteHistoGeneticsAtara BiotherapeuticsActinium PharmaceuticalsGilead SciencesCelgeneCSL BehringBristol-Myers SquibbMallinckrodt PharmaceuticalsSierra OncologyAstellas Pharma USAmgenNational Heart, Lung, and Blood InstituteNovartis Pharmaceuticals CorporationIncytePfizerMedacJazz PharmaceuticalsCTI BiopharmaBe The Match Foundation
KeywordsTransplantationMedicineStem cellMyelofibrosisOncologyInternal medicineBiologyBone marrowGenetics

Abstract

fetched live from OpenAlex

To develop a prognostic model for patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients undergoing allo-HCT between 2000 and 2016 in the United States (the Center for International Blood and Marrow Transplant Research [CIBMTR] cohort). A Cox multivariable model was used to identify factors prognostic of mortality. A weighted score using these factors was assigned to patients who received transplantation in Europe (the European Bone Marrow Transplant [EBMT] cohort; n = 623). Patient age >50 years (hazard ratio [HR], 1.39; 95% confidence interval [CI], 0.98-1.96), and HLA-matched unrelated donor (HR, 1.29; 95% CI, 0.98-1.7) were associated with an increased hazard of death and were assigned 1 point. Hemoglobin levels <100 g/L at time of transplantation (HR, 1.63; 95% CI, 1.2-2.19) and a mismatched unrelated donor (HR, 1.78; 95% CI, 1.25-2.52) were assigned 2 points. The 3-year overall survival (OS) in patients with a low (1-2 points), intermediate (3-4 points), and high score (5 points) were 69% (95% CI, 61-76), 51% (95% CI, 46-56.4), and 34% (95% CI, 21-49), respectively (P < .001). Increasing score was predictive of increased transplant-related mortality (TRM; P = .0017) but not of relapse (P = .12). The derived score was predictive of OS (P < .001) and TRM (P = .002) but not of relapse (P = .17) in the EBMT cohort as well. The proposed system was prognostic of survival in 2 large cohorts, CIBMTR and EBMT, and can easily be applied by clinicians consulting patients with MF about the transplantation outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.757

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.002
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.231
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueBlood AdvancesSame topicMyeloproliferative Neoplasms: Diagnosis and TreatmentFrench-language works237,207